-
Signature
-
/s/ by Mindi Zimmer, as Attorney-in-Fact For: Scott Bibaud
-
Issuer symbol
-
ATOM
-
Transactions as of
-
02 Mar 2026
-
Net transactions value
-
-$49,871
-
Form type
-
4
-
Filing time
-
03 Mar 2026, 20:50:38 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| BIBAUD SCOTT A. |
CEO and President, Director |
C/O ATOMERA, INC., 750 UNIVERSITY AVENUE, SUITE 280, LOS GATOS |
/s/ by Mindi Zimmer, as Attorney-in-Fact For: Scott Bibaud |
03 Mar 2026 |
0001464249 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ATOM |
Common Stock |
Award |
$0 |
+62,022 |
+13% |
$0.000000 |
533,750 |
02 Mar 2026 |
Direct |
F1 |
| transaction |
ATOM |
Common Stock |
Award |
$0 |
+124,044 |
+23% |
$0.000000 |
657,794 |
02 Mar 2026 |
Direct |
F2 |
| transaction |
ATOM |
Common Stock |
Award |
$0 |
+62,022 |
+9.4% |
$0.000000 |
719,816 |
02 Mar 2026 |
Direct |
F3 |
| transaction |
ATOM |
Common Stock |
Sale |
$9,781 |
-1,976 |
-0.27% |
$4.95 |
717,840 |
02 Mar 2026 |
Direct |
F4 |
| transaction |
ATOM |
Common Stock |
Sale |
$24,428 |
-4,935 |
-0.69% |
$4.95 |
712,905 |
02 Mar 2026 |
Direct |
F4 |
| transaction |
ATOM |
Common Stock |
Sale |
$4,905 |
-991 |
-0.14% |
$4.95 |
711,914 |
02 Mar 2026 |
Direct |
F4 |
| transaction |
ATOM |
Common Stock |
Sale |
$10,756 |
-2,173 |
-0.31% |
$4.95 |
709,741 |
02 Mar 2026 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: